Has Michael Wang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,511,545 in general payments to Michael Wang, MD across 1,167 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Wang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Wang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Wang, MD

Neurological Surgery · Miami, FLNPI 1053347906

Payments from drug & device makers

$2,511,545in general payments, 2019–2025

Across 1,167 payments — averaging $2152.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Depuy Synthes Products, Inc.$690K
Medical Device Business Services, Inc.$373K
Spineology Inc.$348K
Medtronic$332K
Stryker$261K
Pfizer$137K
plus $370K from 35 others

$87,560in research payments, 2019–2025

Across 6 payments — averaging $14,593 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Spineology Inc.$80K
Pfizer$8K

What the payments were for

Royalty or licence$818,28337%
Consulting fees$1,132,53752%
Speaking & faculty fees$89,2384%
Travel & lodging$104,9905%
Food & beverage$42,0082%
Education$100%
Gifts$40%
Entertainment$5990%
Ownership interest$10,4000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Depuy Synthes Products, Inc.	32	$690,191
Medical Device Business Services, Inc.	216	$372,748
Spineology Inc.	144	$348,230
Medtronic(2 entities)	191	$332,212
Stryker	175	$260,601
Pfizer	18	$137,289
Globus Medical(2 entities)	165	$128,157
Johnson & Johnson(3 entities)	56	$114,615
Pacira Pharmaceuticals Incorporated	25	$63,797
Surgalign Spine Technologies, Inc.	22	$16,613
VB Spine LLC	13	$16,231
Augmedics Inc.	8	$11,065
Kuros Biosciences USA, Inc	14	$9,203
Joimax, Inc.	5	$3,460
Alphatec Spine, Inc	31	$2,596
Mirus, LLC	3	$696
Integrity Implants Inc.	4	$631
Synthes GmbH	2	$500
4web, Inc.	4	$430
Carlsmed, Inc.	4	$358
Curiteva, Inc.	1	$218
Biocomposites Inc	6	$213
Implanet America, Inc.	1	$189
Si-bone, Inc.	1	$167
Intrinsic Therapeutics	2	$155
Trackx Technology, Inc.	1	$144
Beigene USA, Inc.	2	$106
Elevation Spine, Inc.	3	$104
Integrity Implants Inc. Dba Accelus	1	$82
Baxter Healthcare	2	$79
Heron Therapeutics, Inc.	1	$78
Prosidyan, Inc	1	$77
Biedermann Motech, Inc.	1	$61
Osteocentric Technologies, Inc.	1	$60
Innovasis Inc	1	$46
Seaspine Orthopedics Corporation	1	$43
Amarin Pharma, Inc.	2	$33
Zimmer Biomet	1	$24
Therapeuticsmd, Inc.	1	$22
Astellas Pharma US Inc	1	$19
Innovative Surgical Designs, Inc.	4	$0

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EXPEDIUM$655,169
VIPER$262,430
EXPAREL$229,412
STRATAFIX$135,705
CONCORDE$132,569
DERMABOND$126,160
OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM$101,316
SPOTLIGHT$98,151
Oracle$98,151
MONOCRYL$87,565
PDS$87,565
SURGIFLO Hemostatic Matrix$68,890
RELINE$61,559
Xvision$54,445
EVEREST SPINAL SYSTEM$49,402
SAHARA STABILIZATION SYSTEM$48,259
MAKO$36,233
Rampart Duo Interbody Fusion System$35,195
AVIATOR$29,840
SAHARA$29,521

How this compares

$2,511,545 in reported general payments places this provider in the 95th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$1,152,577

Medicare patients

661

Services billed

2,189

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	474	$6,014
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	155	$4,853
Naloxone Hcl	47	$2,802
Tizanidine Hcl	168	$2,560
Pregabalin	107	$2,296
Celecoxib	87	$2,037
Cyclobenzaprine Hcl	137	$1,746
Methylprednisolone	192	$1,382
Meloxicam	448	$1,223
Diclofenac Sodium	70	$1,214
Baclofen	58	$1,099
Tramadol Hcl	164	$878
Hydromorphone Hcl	18	$394
Methocarbamol	27	$342
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	21	$300

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Miami

Eric PetersonMiami$10.1M
Wilson AsforaMiami$1.3M
Steven VanniMiami$1.2M
Robert StarkeMiami$1M
Cesar GuerreroMiami$914K
Santiago FiguereoMiami$876K
Jonathan JagidMiami$765K
Timur UrakovMiami$652K
Samuel GoldsmitMiami$519K
Ian CoteMiami$231K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →